icon-    folder.gif   Conference Reports for NATAP  
 
  IAS 2017: Conference on HIV Pathogenesis
Treatment and Prevention
Paris, France
July 23-26 2017
Back grey_arrow_rt.gif
 
 
 
Evaluation of lead HIV-1 vaccine regimen in APPROACH: Phase 1/2a study testing heterologous prime boost regimens using mosaic Ad26 and MVA vectors combined with Env protein
 
 
  Reported by Jules Levin
9th IAS Conference on HIV Science (IAS 2017), July 23-26, 2017, Paris
 
Hanneke Schuitemaker
VP, Head Viral Vaccine Discovery and Translational Medicine, Janssen Vaccines and Prevention B.V.
Professor in Virology at the Academic Medical Center, University of Amsterdam IAS | Paris, 24 July 2017

IAS1

IAS2

IAS3

IAS4

IAS5

IAS6

IAS7

IAS8

IAS9

IAS10

IAS11